Andreas Grauer

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Felicia Cosman, Daria B. Crittenden, Jonathan D. Adachi et al. · New England Journal of Medicine · 2016 · 1.6K citations · Full text

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

Kenneth G. Saag, Jeffrey Petersen, Maria Luisa Brandi et al. · New England Journal of Medicine · 2017 · 1.4K citations · Full text

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

Michael R. McClung, Andreas Grauer, Steven Boonen et al. · New England Journal of Medicine · 2014 · 1.2K citations

Underdiagnosis of Vertebral Fractures Is a Worldwide Problem: The IMPACT Study

Pierre D. Delmas, Lex van de Langerijt, Nelson B. Watts et al. · Journal of Bone and Mineral Research · 2005 · 552 citations · Full text

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

Bente Langdahl, Cesar Libanati, Daria B. Crittenden et al. · The Lancet · 2017 · 450 citations

Bone Disease, Sclerostin, Bone Health +7